Iconovo receives a US patent for ICOcap® that strengthens the offering for more customer collaborations

19 September 2023 - 08:30

Iconovo AB (publ), which develops complete inhalation products for a global market, announces today that the U.S. Patent and Trademark Office has approved the company's application for design protection of the ICOcap® inhaler. Iconovo recently regained the global rights to sell and distribute ICOcap® from Stevanato Group and intends to intensify the marketing of the inhaler towards international pharmaceutical companies, while Stevanato Group will act as the exclusive contract manufacturer.

The design protection that the US Patent and Trademark Office has now issued for ICOcap® is valid until May 2037. The inhaler is already protected by patents in Europe. ICOcap® is one of several inhaler platforms that form the basis of Iconovo's customer offering in contract development management (CDMO). Earlier this year, a collaboration project was initiated with Kiox Pharma to develop a new treatment based on ICOcap® for a rare but serious lung disease.

"The fact that we have obtained strong exclusivity protection for ICOcap® in the world's largest pharmaceutical market further strengthens the offering for generating additional collaborative projects with international customers based on our unique inhaler. In addition, it broadens the opportunities for direct sales of the inhalers", says Roger Lassing, Vice President Business Development at Iconovo.

ICOcap® is a patented capsule-based dry powder inhaler with a one-piece-design making it easy to use. It has a robust, unique easy-to-grip design, a patented integrated mouthpiece cover, and low inhalation resistance. A standard version of ICOcap® is available off-the-shelf with the same function and performance as the established inhalers Breezhaler® from Novartis and RS01 from Berry.

Provided by: MFN
Nasdaq First North GM Stockholm (Sweden)
Iconovo AB
Iconovo is engaged in developing proprietary inhalation products for licensing to customers. The company offers ICOres, ICOone, ICOcap, and ICOpre devices....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More